# Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery

> **NCT02860897** · PHASE4 · WITHDRAWN · sponsor: **University Hospitals Cleveland Medical Center**

## Conditions studied

- Estrogen
- Menopause
- Pelvic Floor Disorders
- Surgery

## Interventions

- **DRUG:** Premarin
- **DRUG:** Vagifem

## Key facts

- **NCT ID:** NCT02860897
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-07
- **Primary completion:** 2017-04
- **Final completion:** 2017-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to provide study medications due to cost.
- **Last updated:** 2018-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02860897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02860897, "Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02860897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*